Dr. Reddy’s launches generic version of Pfizer’s Geodon
HYDERABAD, India — Indian drug maker Dr. Reddy’s has launched a drug designed to treat bipolar disorder and schizophrenia, the company said.
The company announced the launch of ziprasidone hydrochloride capsules in the 20-mg, 40-mg, 60-mg and 80-mg strengths.
The drug is a generic version of Pfizer’s Geodon, which had sales of $1.34 billion in 2011, according to IMS Health.
No comments found
Walgreens: Face-to-face consults with pharmacists, retail clinicians reduce health spend
LAS VEGAS — Walgreens last week outlined how the company’s research has demonstrated the ability of face-to-face pharmacy and Take Care Clinic programs to drive better health outcomes at the IMS Managed Markets Services/Data Niche Conference held here.
Some of the savings advantages inherent in the offerings provided by Walgreens include:
The impact of pharmacist-led intervention programs for diabetes patients, which through face-to-face counseling have been found in a recent study to drive a statistically significant reduction in levels for A1C, blood pressure and LDL;
The impact of community pharmacy on influenza immunizations, where a recent retrospective study showed that in 2009-2010, more than one-third of Walgreens flu immunizations were administered in pharmacies located in medically underserved areas. In states with the largest MUAs, Walgreens provided up to 77% of its flu shots in MUAs; and
The effect of pharmacists educating at-risk patients on the importance of receiving a pneumococcal vaccination. The study found 4.9% of the at-risk population immunized for pneumococcal disease, compared with 2.9% of at-risk patients in a traditional care benchmark population. The difference is an increase of 68% over benchmark.
"The power of pharmacist and nurse practitioner-led, face-to-face programs is clearly demonstrated," stated Robert London, Walgreens national medical director. "Whether delivered through a community pharmacy, retail clinic or worksite health center, these interactions allow for an individualized approach to disease management while meaningfully improving health outcomes," he said. "The Medicaid population in particular stands to benefit from these types of outcomes-driven, face-to-face programs. With a huge expansion in the Medicaid eligible population looming, cost control becomes even more important. It will be vital to find solutions, such as those offered by Walgreens, to help improve patient health while ultimately reducing costs."
No comments found
CVS/pharmacy promotes importance of a ‘pharmacy home’
WOONSOCKET, R.I. — CVS/pharmacy is looking to help pharmacy customers on their path to better health through improved medication adherence as guidance gained from the company’s extensive health policy research points to the importance of a single “pharmacy home.”
"These research-based facts are important for all patients taking medications to understand so they not only feel better, but also save money," stated Papatya Tankut, VP professional pharmacy services at CVS/pharmacy. "This is especially true for older patients who take two to three times as many prescription medications as those under 65. With the first baby boomers turning 65 — and 10,000 people in the United States turning 65 every day for the next eight years — this group is growing."
The guidance is gained from CVS Caremark’s health policy research with Harvard University and Brigham and Women’s Hospital.
Having a "pharmacy home" for all of their prescriptions helps patients guard against potential drug interactions. It also encourages the development of a relationship with their pharmacist, who can counsel on the role of medications in treating their health conditions and the importance of staying on prescription therapies to improve their health and reduce their overall healthcare costs, according to CVS Caremark.
"A pharmacist in a face-to-face setting is the most effective healthcare professional at encouraging patients to take medications as prescribed," Tankut added. "When patients fill all of their prescriptions at CVS/pharmacy, our pharmacists are in a better position to help them on their path to better health."
CVS/pharmacy is inviting patients to share their stories of how CVS pharmacists have helped them stay healthy and save money. Now available at Facebook.com/CVS, myCVS Pharmacist Story features comments from patients sharing experiences involving their own care, that of their children or others for whom they are serving as caregivers.
I completely agree with Rebru. We have had the same issue from CVS/Caremark. Some of their letters to our patient even insinuate that the patients will pay a higher copay if they do not switch. This has upset many of my patients and they change out of fear even if we try to explain that it is not true. As you stated, face to face is what we want but only if it is the CVS/Caremark face.
What is this? If CVS/Caremark REALLY feels this way, they would not be sending letters to my patients that trade at a competitor telling them they must change to CVS to continue using their new Caremark insurance. I have had at least a dozen patients tell me this in the last 2 weeks.. some have traded at my store for longer that 20 years. A pharmacist in a face-to-face setting is the most effective.. But then tell my patients it must be their face or they must use the Caremark Mail order. I surely hate when companies talk out of both sides of their face like this!